Haier Biomedical's Controlling Shareholder Proposes Share Buyback Program Valued Between RMB 50 Million and RMB 100 Million

Stock News06-25

The controlling shareholder of Qingdao Haier Biomedical Co.,Ltd. (SH: 688139) has submitted a formal proposal for the company to repurchase its own shares.

The proposal, received by the company on June 25, 2026, from its controlling shareholder, Qingdao Haier Biomedical Holding Co., Ltd., suggests a buyback using the company's own funds.

The recommended repurchase would be executed through centralized competitive bidding on the Shanghai Stock Exchange system, targeting a portion of the company's issued A-shares.

The total amount earmarked for the share repurchase is proposed to be no less than RMB 50 million and no more than RMB 100 million.

The final details of the share repurchase plan will be subject to approval and formalization by the company's board of directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1198669369?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-25 18:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198669369","market":"other","top_or_hot":-1,"title":"Haier Biomedical's Controlling Shareholder Proposes Share Buyback Program Valued Between RMB 50 Million and RMB 100 Million","media":"Stock News","content":"<p>The controlling shareholder of <b>Qingdao Haier Biomedical Co.,Ltd.</b> (<b>SH: 688139</b>) has submitted a formal proposal for the company to repurchase its own shares.<br><br>The proposal, received by the company on June 25, 2026, from its controlling shareholder, Qingdao Haier Biomedical Holding Co., Ltd., suggests a buyback using the company's own funds.<br><br>The recommended repurchase would be executed through centralized competitive bidding on the Shanghai Stock Exchange system, targeting a portion of the company's issued A-shares.<br><br>The total amount earmarked for the share repurchase is proposed to be no less than RMB 50 million and no more than RMB 100 million.<br><br>The final details of the share repurchase plan will be subject to approval and formalization by the company's board of directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Haier Biomedical's Controlling Shareholder Proposes Share Buyback Program Valued Between RMB 50 Million and RMB 100 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHaier Biomedical's Controlling Shareholder Proposes Share Buyback Program Valued Between RMB 50 Million and RMB 100 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-25 18:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The controlling shareholder of <b>Qingdao Haier Biomedical Co.,Ltd.</b> (<b>SH: 688139</b>) has submitted a formal proposal for the company to repurchase its own shares.<br><br>The proposal, received by the company on June 25, 2026, from its controlling shareholder, Qingdao Haier Biomedical Holding Co., Ltd., suggests a buyback using the company's own funds.<br><br>The recommended repurchase would be executed through centralized competitive bidding on the Shanghai Stock Exchange system, targeting a portion of the company's issued A-shares.<br><br>The total amount earmarked for the share repurchase is proposed to be no less than RMB 50 million and no more than RMB 100 million.<br><br>The final details of the share repurchase plan will be subject to approval and formalization by the company's board of directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0251","symbol_name":"专用设备","start_time":0,"source_url":"","article_id":"1198669369","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198669369","pubTimestamp":1782381989,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"The controlling shareholder of Qingdao Haier Biomedical Co.,Ltd. (SH: 688139) has submitted a formal proposal for the company to repurchase its own shares.The proposal, received by the company on...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688139":"海尔生物","BK0251":"专用设备","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC"},"translate_title":"海尔生物医疗控股股东提出5000万至1亿元股份回购计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688139":1},"content_text":"The controlling shareholder of Qingdao Haier Biomedical Co.,Ltd. (SH: 688139) has submitted a formal proposal for the company to repurchase its own shares.The proposal, received by the company on June 25, 2026, from its controlling shareholder, Qingdao Haier Biomedical Holding Co., Ltd., suggests a buyback using the company's own funds.The recommended repurchase would be executed through centralized competitive bidding on the Shanghai Stock Exchange system, targeting a portion of the company's issued A-shares.The total amount earmarked for the share repurchase is proposed to be no less than RMB 50 million and no more than RMB 100 million.The final details of the share repurchase plan will be subject to approval and formalization by the company's board of directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1198669369","isCrawlerRequest":true}